-
Mashup Score: 2Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors | Monte Rosa Therapeutics - 1 year(s) ago
BOSTON, March 23, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a clinical stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the appointment of Jan Skvarka, Ph.D., MBA to its Board of Directors. Dr.
Source: Monte Rosa TherapeuticsCategories: Hem/Oncs, Latest HeadlinesTweet
RT @MonteRosaTx: We are excited to have @jskvarka join our Board of Directors, read the full press release here: https://t.co/lwY7yJhRXt ht…